Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 20;1(1):e000022.
doi: 10.1136/rmdopen-2014-000022. eCollection 2015.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide

Affiliations
Review

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide

Raphaèle Seror et al. RMD Open. .

Abstract

The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) is a systemic disease activity index that was designed to measure disease activity in patients with primary SS. With the growing use of the ESSDAI, some domains appear to be more challenging to rate than others. The ESSDAI is now in use as a gold standard to measure disease activity in clinical studies, and as an outcome measure, even a primary outcome measure, in current randomised clinical trials. Therefore, ensuring an accurate and reproducible rating of each domain, by providing a more detailed definition of each domain, has emerged as an urgent need. The purpose of the present article is to provide a user guide for the ESSDAI. This guide provides definitions and precisions on the rating of each domain. It also includes some minor improvement of the score to integrate advance in knowledge of disease manifestations. This user guide may help clinicians to use the ESSDAI, and increase the reliability of rating and consequently of the ability to detect true changes over time. This better appraisal of ESSDAI items, along with the recent definition of disease activity levels and minimal clinically important change, will improve the assessment of patients with primary SS and facilitate the demonstration of effectiveness of treatment for patients with primary SS.

Keywords: Disease Activity; Outcomes research; Sjögren's Syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Body surface area.

References

    1. Seror R, Ravaud P, Bowman SJ et al. . EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1103–9. 10.1136/ard.2009.110619 - DOI - PMC - PubMed
    1. Seror R, Ravaud P, Mariette X et al. ; EULAR Sjögren's Task Force. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011;70:968–72. 10.1136/ard.2010.143743 - DOI - PubMed
    1. Seror R, Mariette X, Bowman S et al. . Accurate detection of changes in disease activity in primary Sjogren's syndrome by the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index. Arthritis Care Res (Hoboken) 2010;62:551–8. 10.1002/acr.20173 - DOI - PubMed
    1. Seror R, Theander E, Brun JG et al. ; on behalf of the EULAR Sjögren's Task Force. Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2014. Published Online First 10.1136/annrheumdis-2013-204615 - DOI - PubMed
    1. Gottenberg JE, Seror R, Miceli-Richard C et al. . Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjogren's syndrome. Data at enrollment in the prospective ASSESS cohort. PLoS ONE 2013;8:e59868 10.1371/journal.pone.0059868 - DOI - PMC - PubMed